Sandbox:Shadan: Difference between revisions
Jump to navigation
Jump to search
| Line 80: | Line 80: | ||
***BRCA2 modifier gene: PALB2 | ***BRCA2 modifier gene: PALB2 | ||
** Low risk | ** Low risk | ||
***These alleles have not designated | ***These alleles have not designated yet. | ||
Endogenous hormone exposure and reproductive factors: | |||
* Early menarche;under age of 13 years | |||
*Parity; nulliparous is associated with incresed risk of breast cancer | |||
*Age at first full term pregnancy; younger age may decrease risk of breast cancer | |||
*Breast feeding; decreased risk of breast cancer | |||
* Testostrone; increased relative risk to 2.86-3.28 | |||
*Age at menopause;older menopausal age associated with greater risk of breast cancer | |||
Exogenous hormone exposure | |||
*long term exposure> 5 years; increases chances of breast cancer | |||
*Time of usage;nearly menopausal age associated with development to breast cancer | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 20:17, 6 December 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]
Overview
Classification
Classification of breast lumps based on epithelial hyperplasia[1]
- Approximately 65% of all benign breast disease considered as nonproliferative(NP)with relative cancer risk of 1.2, 1.4 times:
- Simple cyst
- Fibrosis
- Fibroadenoma (simple)
- Columnar alteration (Simple)
- Apocrine metaplasia (simple)
- Mild ductal hyperplasia
- Approximately 30% of total are classifed as proliferative disease(PD) with relative cancer risk of 1.7, 2.1 times
- Usual ductal hyperplasia
- Sclerosing adenosis
- Columnar hyperplasia
- papilloma
- Radical scar
- Approximately 5% to 8% of the rest regarded to PD with atypia with relative cancer risk more than 4 times
- Atypical lobar hyperplasia
- Lobular carcinoma in situ
- Atypical ductal hyperplasia
- Unclear risk
- Mucocele like tumor
- Apocrine atypia
- Secretory atypia
Classification of benign breast lesion regarding to histological region:[2]
- Terminal and lobular ducts
- Acinar distention
- Cyst
- Intralobular connective tissue proliferation
- Sclerosing adenosis
- Fibroadenoma
- Phyllodes tumor
- Hamartoma
- Epithelial changes in terminal duct lobaular units (TDLU)
- Apocrine metaplasia
- Ductal and lobular hyperplasia, usual and typical
- Papillomatosis
- Intracystic papilloma
- Acinar distention
- Ductal system
- Ductal ectasia
- Intraductal papilloma
- Lesion of different origin
- Fatty tissue lesion
- Lipoma
- Liponecrosis
- Fibrous tissue lesions
- Focal fibrosis
- Diabetic mastopathy
- Pseudoangiomatous stromal hyperplasia (PASH)
- Myofibroblastoma
- Vascular origin
- Hemangioma
- Inflammatory origin
- Mastitis/abscess
- Tuberclosis and sarcoidosis
- Foreign body granuloma and siliconoma
- Lymph node origin
- Inflammatory lymoh nodes
- Fatty tissue lesion
Risk factors
Associated risk factors leading to female breast cancer:
- Age: probability of breast cancer from birth to 39 years; 1 in 202, from 40 to 59 years; 1 in 26, from 60 to 69 years; 1 in 28.
- Personal history of breast cancer
- Breast pathology: PD with atypia has greater risk of developing to breast cancer in comparison of PD.
- Family history: greater breast cancer risk in women with first degree relatives with breast cancer under 50 years old.
- Genetic predisposition
- High risk
- BRCA1
- BRCA2
- Moderate risk
- Homozygous ataxia-telangiectasia (ATM)
- Somatic mutation in CHEK2
- BRCA1 modifier gene: BRIP1
- BRCA2 modifier gene: PALB2
- Low risk
- These alleles have not designated yet.
- High risk
Endogenous hormone exposure and reproductive factors:
- Early menarche;under age of 13 years
- Parity; nulliparous is associated with incresed risk of breast cancer
- Age at first full term pregnancy; younger age may decrease risk of breast cancer
- Breast feeding; decreased risk of breast cancer
- Testostrone; increased relative risk to 2.86-3.28
- Age at menopause;older menopausal age associated with greater risk of breast cancer
Exogenous hormone exposure
- long term exposure> 5 years; increases chances of breast cancer
- Time of usage;nearly menopausal age associated with development to breast cancer
References
- ↑ Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K; et al. (2005). "Benign breast disease and the risk of breast cancer". N Engl J Med. 353 (3): 229–37. doi:10.1056/NEJMoa044383. PMID 16034008.
- ↑ Lanyi, M (2003). Mammography : diagnosis and pathological analysis. Berlin New York: Springer-Verlag. ISBN 9783540441137.